Resuscitating a Dying Marrow:
Emerging Concepts and Treatment
Advances in Myeloid Malignancies Webcasts
Emerging Concepts and Treatment Advances in Myeloid Malignancies Case-Based Discussion
Release date: January 17, 2022
Expiration date: January 17, 2024
Estimated Time of Completion: 45 minutes
Description
The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty member has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
Sudipto Mukherjee, MD | |
Aplastic Anemia and MDS International Foundation | Honorarium - Activity Director of ASH Friday Satellite Symposium 2020 |
Eusa Pharma | Consulting Advisor or review panel participant Teaching and Speaking |
Novartis | Consulting Research / Independent Contractor Advisor or review panel participant |
McGraw Hill | Honoraria - Editor of Hematology Oncology Board Review (ongoing) |
Bristol-Myers Squibb Co. | Advisor or review panel participant Honoraria |
Celgene Corporation | Board Membership Consulting Research / Independent Contractor Advisor or review panel participant Research Funding - non-therapeutic investigator trials. Formerly Celgene (now BMS) |
Naveen Pemmaraju, MD | |
Pacylex Pharmaceuticals | Consulting |
ImmunoGen, Inc | Consulting |
Bristol-Myers Squibb Co. | Consulting |
Blueprint Medicines | Consulting |
Clearview Healthcare Partners | Consulting |
Protagonist Therapeutics, Inc. | Consulting |
Affymetrix | Consulting |
Incyte | Consulting |
Novartis Pharmaceuticals | Consulting Research support. |
LFB Biotechnologies | Consulting |
Stemline Therapeutics, Inc. | Consulting Advisor or review panel participant. Research support. |
Celgene Corporation | Consulting |
Abbvie Pharmaceuticals | Consulting Advisor or review panel participant. Research support. |
MustangBio | Consulting Research support. |
Roche Diagnostics | Consulting |
DAVA Oncology | Consulting |
Springer Science + Business Media | Invited authorship. |
Aptitude Health | Consulting |
CareDx, Inc. | Consulting |
Cellectis S.A. ADR | Research support. |
Daiichi Sankyo, Inc. | Research support. |
Plexxicon | Research support. |
Samus | Research support. |
ASH Communications Committee | Board Membership |
ASCO Leukemia Advisory Panel | Board Membership Advisor or review panel participant. |
HemOnc Times/Oncology Times | Board Membership |
Dan's House of Hope | Board Membership |
Antonio Risitano, MD | |
Alexion | Board Membership Teaching and Speaking |
Apellis Pharmaceuticals | Board Membership Teaching and Speaking |
Novartis | Board Membership Consulting Research / Independent Contracto Teaching and Speaking |
Pfizer | Board Membership Research / Independent Contractor Teaching and Speaking |
BioCryst Pharmaceuticals, Inc. | Board Membership Consulting |
Roche | Board Membership Consulting |
Yogen Saunthararajah, MD | |
Epidestiny LLC | Board Membership Consulting Intellectual property rights (Royalties or patent sales) Ownership interest (stock, stock options in a publicly owned company) |
Acknowledgement
The Aplastic Anemia and MDS International Foundation and Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this internet enduring activity from:
Alexion Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.
Ascentage Pharma Group, Inc.
Biocryst Pharmaceuticals Inc.
Bristol-Myers Squibb
Geron Corporation
Taiho Oncology
Takeda Oncology
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Taussig Cancer Institute and Aplastic Anemia & MDS International Foundation.